Abstract:Objective A novel photosensitizer I was synthesized in our laboratory by linking photosensitizer chlorin with folic acid, a targeting group, through PEG linker. The aim of this paper is to evaluate the targeting and photodynamic activities of photosensitizerⅠfor laryngeal carcinoma Hep-2 cells and nasopharyngeal carcinoma CNE cells. Methods The expression of folate receptor in Hep-2 cells and CNE cells was detected by Western blot. The cellular phagocytosis of photosensitizerⅠby Hep-2 cells and CNE cells with or without the presence of excessive folic acid were tested with fluorescence spectroscopy. The cytotoxicity of photosensitizerⅠagainst Hep2 cells and CNE cells with or without irradiation, and the effects of photosensitizer concentration and the irradiation dose on the viability of Hep2 cells and CNE cells were measured by MTT assays. Results Western blot analysis revealed moderate expression of folate receptor in Hep2 cells, and weak expression in CNE cells. The cellular phagocytosis of photosensitizer I by both Hep2 cells and CNE cells increased with the concentration of photosensitizer, and the phagocytic activity of Hep2 cells was stronger than that of CNE cells (P<0.01). The presence of excessive free folic acid could competitively inhibit the phagocytic activity of Hep2 cells. The results of MTT assays demonstrated that photosensitizerⅠexhibited significant photocytotoxicity for both Hep2 cells and CNE cells, and the photodynamic activity of photosensitizer I was positively correlated with the concentration of photosensitizer and the irradiation dose. Conclusion Photosensitizer I displays clear targeting and photodynamic activity for laryngeal carcinoma Hep2 cells with high level expression of folate receptor.